Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
To the Editor:
Tsimikas et al. (Jan. 16 issue)
1
report a dose-dependent reduction in lipoprotein(a) levels after the administration of the antisense oligonucleotide AKCEA-APO(a)-L
Rx
, referred to here as APO(a)-L
Rx
, in patients with elevated lipoprotein(a) levels and established cardiovascular disease. The safety analysis s...
Alternative Titles
Full title
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2405327473
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2405327473
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMc2004861
